Bristol-Myers Squibb Co (NYSE:BMY)

65.86
Delayed Data
As of Apr 20
 +0.51 / +0.78%
Today’s Change
46.30
Today|||52-Week Range
69.20
+11.57%
Year-to-Date
Merck's Keytruda Tops Melanoma, Lung Cancer Studies - Analyst Blog
Apr 20 / Zacks.com
Bristol-Myers Squibb Company (BMY) Strong In Pre-Market Trading
Apr 17 / TheStreet.com
Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog
Apr 20 / Zacks.com
The Best Stock to Invest in Hep C
Apr 16 / MotleyFool.com
CAR-T Therapy Stocks Hit Hard Following AACR Data
Apr 20 / Benzinga
The Medicines Co.'s Kengreal Briefing Documents Positive - Analyst Blog
Apr 14 / Zacks.com
Bristol-Myers combination melanoma treatment shows promise
Apr 20 / FT.com
Is Now the Time to Buy Bank Stocks and Sell Growth Companies?
Apr 14 / TheStreet.com
Bristol-Myers Squibb Reports First Randomized Study Evaluating Opdivo+Yervoy Regimen ...
Apr 20 / Benzinga
Today's Stocks Driving Success For The Drugs Industry
Apr 14 / TheStreet.com
Is Bristol-Myers Squibb. Co. About to Fall Apart?
Apr 20 / MotleyFool.com
Advaxis Shares Rise Ahead of Aduro's Rival Cancer Immunotherapy IPO
Apr 14 / TheStreet.com
Best Pure Play Investment in Cancer Drugs
Apr 19 / MotleyFool.com
2 Speculative Biotechs That Could Be Well Worth the Risk
Apr 14 / MotleyFool.com
Merck Seeks Expanded Approval of Keytruda Immunotherapy to Treat Lung Cancer
Apr 19 / TheStreet.com
AstraZeneca's Onglyza Briefing Documents Raise Concern - Analyst Blog
Apr 13 / Zacks.com
It's A Big Weekend For Biotech
Apr 17 / Benzinga
Biotech: Making sense of the science
Apr 13 / FT.com
Bristol-Myers to Transfer Certain Erbitux Rights to Eli Lilly - Analyst Blog
Apr 17 / Zacks.com
Celldex Initiates Study on Varlilumab for Metastatic Melanoma - Analyst Blog
Apr 07 / Zacks.com
Why Bristol-Myers Squibb Ending A Drug Trial Early Is A Good Thing
Apr 17 / Benzinga
Company News for April 07, 2015 - Corporate Summary
Apr 07 / Zacks.com
Bristol-Myers Up Big After Drug Study Stopped Early
Apr 17 / Benzinga
Big pharma turns to small biotechs for edge in cancer treatment
Apr 07 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account